Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Schriftenreihe:	Проблемы особо опасных инфекций
Schlagworte:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Online Zugang:	https://journal.microbe.ru/jour/article/view/254

Ähnliche Einträge

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
von: E. I. Kazachinskaya, et al.
Veröffentlicht: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
von: Alexey Alekseevich Andreev, et al.
Veröffentlicht: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
von: A. A. Petrov, et al.
Veröffentlicht: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
von: A. A. Sominina, et al.
Veröffentlicht: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
von: A. V. Philippova, et al.
Veröffentlicht: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
von: Zh. I. Avdeeva, et al.
Veröffentlicht: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
von: V. V. Tiguntsev, et al.
Veröffentlicht: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
von: N. P. Khrapova, et al.
Veröffentlicht: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
von: A. V. Philippova, et al.
Veröffentlicht: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
von: A. A. Petrov, et al.
Veröffentlicht: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
von: O. O. Fomenkov, et al.
Veröffentlicht: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
von: D. A. Lozovoy, et al.
Veröffentlicht: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
von: N. E. Tereshkina, et al.
Veröffentlicht: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
von: А. С. Пастиря, et al.
Veröffentlicht: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
von: I. I. Korsakova, et al.
Veröffentlicht: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
von: T. E. Sizikova, et al.
Veröffentlicht: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
von: T. V. Kozhanova
Veröffentlicht: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
von: A V Labushkina, et al.
Veröffentlicht: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
von: A. A. Soldatov, et al.
Veröffentlicht: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
von: N. V. Bogacheva, et al.
Veröffentlicht: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
von: N. N. Lugovskaya, et al.
Veröffentlicht: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Veröffentlicht: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
von: С. С. Бобкова, et al.
Veröffentlicht: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
von: D. L. Klabukova, et al.
Veröffentlicht: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
von: Владимир Сергеевич Журавлев, et al.
Veröffentlicht: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
von: I. V. Lyagoskin, et al.
Veröffentlicht: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
von: Елена Борисовна Лукоянычева, et al.
Veröffentlicht: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
von: M. L. Dmitriyeva, et al.
Veröffentlicht: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
von: G. N. Leonova, et al.
Veröffentlicht: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
von: A. A. Lidzhieva, et al.
Veröffentlicht: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
von: N. T. Tikhonova, et al.
Veröffentlicht: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
von: A. N. Mokrievich, et al.
Veröffentlicht: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
von: A. V. Vatazin, et al.
Veröffentlicht: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
von: V. G. Dedkov, et al.
Veröffentlicht: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
von: L. Yu. Aksenova, et al.
Veröffentlicht: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
von: J Zabek
Veröffentlicht: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
von: Sonia Ivanova, et al.
Veröffentlicht: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
von: - Bayati Ali Hattem Hussein, et al.
Veröffentlicht: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
von: A. A. Lopatin, et al.
Veröffentlicht: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
von: A. A. Petrov, et al.
Veröffentlicht: (2014-09-01)